GENinCode (LON:GENI) Trading Up 9.5% – Should You Buy?

GENinCode Plc (LON:GENI)’s share price was up 9.5% during mid-day trading on Wednesday . The company traded as high as GBX 1.15 and last traded at GBX 1.15. Approximately 6,340,111 shares traded hands during trading, an increase of 9% from the average daily volume of 5,811,077 shares. The stock had previously closed at GBX 1.05.

GENinCode Stock Up 10.5%

The company has a current ratio of 2.80, a quick ratio of 15.89 and a debt-to-equity ratio of 7.17. The stock’s 50-day moving average is GBX 1.12 and its 200-day moving average is GBX 1.59. The company has a market cap of £8.41 million, a price-to-earnings ratio of -0.49 and a beta of 0.61.

About GENinCode

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.